JP2024519188A5 - - Google Patents
Info
- Publication number
- JP2024519188A5 JP2024519188A5 JP2024515728A JP2024515728A JP2024519188A5 JP 2024519188 A5 JP2024519188 A5 JP 2024519188A5 JP 2024515728 A JP2024515728 A JP 2024515728A JP 2024515728 A JP2024515728 A JP 2024515728A JP 2024519188 A5 JP2024519188 A5 JP 2024519188A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- groups
- cancer
- general formula
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110565410.0 | 2021-05-24 | ||
| CN202110565410 | 2021-05-24 | ||
| CN202110694022.2 | 2021-06-22 | ||
| CN202110694022 | 2021-06-22 | ||
| CN202110856289 | 2021-07-28 | ||
| CN202110856289.7 | 2021-07-28 | ||
| CN202210198679.4 | 2022-03-02 | ||
| CN202210198679 | 2022-03-02 | ||
| PCT/CN2022/094612 WO2022247816A1 (zh) | 2021-05-24 | 2022-05-24 | 含氮杂环类化合物、其制备方法及其在医药上的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519188A JP2024519188A (ja) | 2024-05-08 |
| JP2024519188A5 true JP2024519188A5 (https=) | 2025-06-03 |
Family
ID=84229501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515728A Pending JP2024519188A (ja) | 2021-05-24 | 2022-05-24 | 含窒素複素環系化合物、その調製方法及びその医薬的応用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240287094A1 (https=) |
| EP (1) | EP4349836A4 (https=) |
| JP (1) | JP2024519188A (https=) |
| KR (1) | KR20240012437A (https=) |
| CN (1) | CN117177971A (https=) |
| AU (1) | AU2022280845A1 (https=) |
| BR (1) | BR112023022496A2 (https=) |
| CA (1) | CA3219858A1 (https=) |
| MX (1) | MX2023013890A (https=) |
| TW (1) | TW202313630A (https=) |
| WO (1) | WO2022247816A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102867210B1 (ko) | 2021-10-01 | 2025-10-14 | 신테라, 인크. | 아제티딘 및 피롤리딘 parp1 저해제, 및 이의 용도 |
| CN120081844A (zh) | 2022-01-21 | 2025-06-03 | 新特拉有限公司 | Parp1抑制剂及其用途 |
| AU2023235233A1 (en) | 2022-03-14 | 2024-09-12 | Slap Pharmaceuticals Llc | Multicyclic compounds |
| AU2023259236B2 (en) | 2022-04-28 | 2025-01-09 | Xinthera, Inc. | Tricyclic parp1 inhibitors and uses thereof |
| WO2024041643A1 (zh) * | 2022-08-25 | 2024-02-29 | 江苏恒瑞医药股份有限公司 | 稠合三环类化合物、其制备方法及其在医药上的应用 |
| CN120035596A (zh) * | 2022-11-23 | 2025-05-23 | 江苏恒瑞医药股份有限公司 | 一种含氮杂环类化合物的可药用盐、晶型及制备方法 |
| KR20260021657A (ko) | 2023-06-08 | 2026-02-13 | 상하이 센후이 메디슨 컴퍼니 리미티드 | 포름아미드계 화합물의 제조 방법 |
| WO2024255697A1 (zh) * | 2023-06-13 | 2024-12-19 | 中国医药研究开发中心有限公司 | 含氮杂环类化合物及其医药用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4138564A (en) * | 1977-08-03 | 1979-02-06 | American Home Products Corporation | Tetrahydro[1H]pyrazino[1,2-a]azaquinoxalin-5(6H)-ones and derivatives thereof |
| AUPS137402A0 (en) * | 2002-03-26 | 2002-05-09 | Fujisawa Pharmaceutical Co., Ltd. | Novel tricyclic compounds |
| US8299256B2 (en) | 2007-03-08 | 2012-10-30 | Janssen Pharmaceutica Nv | Quinolinone derivatives as PARP and TANK inhibitors |
| US8404713B2 (en) | 2007-10-26 | 2013-03-26 | Janssen Pharmaceutica Nv | Quinolinone derivatives as PARP inhibitors |
| CN102372716A (zh) * | 2010-08-09 | 2012-03-14 | 江苏恒瑞医药股份有限公司 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
| TWI693218B (zh) | 2014-11-14 | 2020-05-11 | 美商美國禮來大藥廠 | 極光ａ激酶抑制劑 |
| TWI715291B (zh) * | 2018-11-16 | 2021-01-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | 包含parp抑制劑的藥物組合物 |
| SI3999506T1 (sl) * | 2019-07-19 | 2025-06-30 | Astrazeneca Ab | Zaviralci PARP1 |
| AU2021298145A1 (en) | 2020-06-24 | 2023-02-09 | Itf Research Pharma, S.L.U | Soft gelatin capsules |
| US11795158B2 (en) | 2020-06-25 | 2023-10-24 | Astrazeneca Ab | Chemical compounds |
| US11591331B2 (en) * | 2021-04-19 | 2023-02-28 | Xinthera, Inc. | PARP1 inhibitors and uses thereof |
| JP7835895B2 (ja) * | 2022-05-07 | 2026-03-25 | サイブランチ セラピューティクス カンパニー リミテッド | Ｐａｒｐ１を選択的に阻害するフルオロキノキサリノン誘導体 |
-
2022
- 2022-05-24 BR BR112023022496A patent/BR112023022496A2/pt unknown
- 2022-05-24 JP JP2024515728A patent/JP2024519188A/ja active Pending
- 2022-05-24 CA CA3219858A patent/CA3219858A1/en active Pending
- 2022-05-24 MX MX2023013890A patent/MX2023013890A/es unknown
- 2022-05-24 EP EP22810541.7A patent/EP4349836A4/en active Pending
- 2022-05-24 WO PCT/CN2022/094612 patent/WO2022247816A1/zh not_active Ceased
- 2022-05-24 TW TW111119308A patent/TW202313630A/zh unknown
- 2022-05-24 US US18/562,127 patent/US20240287094A1/en active Pending
- 2022-05-24 CN CN202280027629.8A patent/CN117177971A/zh active Pending
- 2022-05-24 KR KR1020237042926A patent/KR20240012437A/ko active Pending
- 2022-05-24 AU AU2022280845A patent/AU2022280845A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024519188A5 (https=) | ||
| CN111295384A (zh) | 双环类衍生物抑制剂、其制备方法和应用 | |
| JP2024522766A5 (https=) | ||
| JP2019529500A5 (https=) | ||
| US20190269783A1 (en) | Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors | |
| JP2019535720A5 (https=) | ||
| CN111989332A (zh) | 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用 | |
| JP2019529444A5 (https=) | ||
| JP2024529068A5 (https=) | ||
| CN1642542A (zh) | 血管新生抑制剂 | |
| JP2023530456A5 (https=) | ||
| IL319292A (en) | Cytotoxic imidazo[2,1-A]pyridine compounds and their use in therapy | |
| JP2019509986A (ja) | トリプトライドのグルコース・コンジュゲート、その類縁体及び使用 | |
| US20250154098A1 (en) | Substituted bisphenylalkylurea compounds and methods of treating breast cancer | |
| JP2020503376A5 (https=) | ||
| JP2020534300A5 (https=) | ||
| JP2017503753A5 (https=) | ||
| EP2144887A1 (en) | Dosages and methods for the treatment of cancer | |
| JP2025111532A (ja) | ５－ブロモピリジン－３－イル－３－デオキシ－３－［４－（３，４，５－トリフルオロフェニル）－１ｈ－１，２，３－トリアゾール－１－ｙｌ］－１－チオ－アルファ－ｄ－ガラクトピラノシド及びその結晶形を調製するための大規模方法 | |
| EP4591940A3 (en) | Deoxy- cytidine derivatives for use in cancer therapies | |
| JP2005531563A5 (https=) | ||
| JP2018140987A5 (https=) | ||
| KR102138415B1 (ko) | 신규 peg 유도체 | |
| US9499552B2 (en) | Pyrazolo[1,5-A]pyrimidine derivative and use of anti-tumor thereof | |
| US20160102066A1 (en) | Benzothiazole derivative and anti-tumor use thereof |